Distinguished Professor, UCSF Director, Bixby Center for Global Reproductive Health
Obstetrics & Gynecology
Dr. Philip D. Darney, MD
|
|
Give Review
Philip Darney works in the field of Obstetrics & Gynecology. He went to University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is one of the top medical schools in the US. University of California San Francisco School of Medicine is ranked 3/3 in Research/PrimaryCare. He received 3 awards: "Elected Member", "Fellow (FACOG)" and "Whos Who in Medicine and Healthcare". Philip D. Darney, MD is a published doctor and has 67 publications published. The lastest was: 'Public Funding for Contraception, Provider Training, and Use of Highly Effective Contraceptives: A Cluster Randomized Trial.'
Publications
- Public Funding for Contraception, Provider Training, and Use of Highly Effective Contraceptives: A Cluster Randomized Trial.
- Onsite provision of specialized contraceptive services: does title x funding enhance access?
- Long-acting reversible contraceptive training intervention: results from a cluster randomized trial on pregnancy outcomes.
- Interpregnancy Intervals: Impact of Postpartum Contraceptive Effectiveness and Coverage.
- Association of Access to Publicly Funded Family Planning Services With Adolescent Birthrates in California Counties.
- Intrauterine contraception: impact of provider training on participant knowledge and provision.
- Postpartum contraception in publicly-funded programs and interpregnancy intervals.
- Medical education and family planning: Developing future leaders and improving global health.
- A statement on abortion by 100 professors of obstetrics: 40 years later.
- Access to levonorgestrel emergency contraception: science versus federal politics.
- Long-acting reversible contraception method use among Title X providers and non-Title X providers in California.
- Evidence-based IUD Practice: Family Physicians and Obstetrician-Gynecologists.
- Comparison of Adherence to Chlamydia Screening Guidelines Among Title X Providers and Non-Title X Providers in the California Family Planning, Access, Care, and Treatm...
- Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17β-estradiol: a randomized controlled trial.
- Evaluation of the london measure of unplanned pregnancy in a United States population of women.
- Multi-specialty family planning training: collaborating to meet the needs of women.
- The future of contraception: the future leaders of family planning.
- Family planning and the future.
- Estimating the Fertility Effect of Expansions of Publicly Funded Family Planning Services in California.
- Financial effect of instituting Deficit Reduction Act documentation requirements in family planning clinics in Oregon.
- Sex-selective abortion in Nepal: a qualitative study of health workers' perspectives.
- Should providers give women advance provision of emergency contraceptive pills? A cost-effectiveness analysis.
- Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications.
- Cost-benefit analysis of state- and hospital-funded postpartum intrauterine contraception at a university hospital for recent immigrants to the United States.
- The financial effects of expanding postpartum contraception for new immigrants.
- Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
- Ethics and referral for abortion.
- Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials.
- Insertion of intrauterine contraceptives immediately following first- and second-trimester abortions.
- Cost savings from the provision of specific methods of contraception in a publicly funded program.
- Challenges in translating evidence to practice: the provision of intrauterine contraception.
- Uterine artery embolization in postabortion hemorrhage.
- Predictors of delay in each step leading to an abortion.
- Predictors of abortion provision among practicing obstetrician-gynecologists: a national survey.
- Risk factors for repeat elective abortion.
- Injectable contraception.
- Pharmacy access to emergency contraception: Perspectives of pharmacists at a chain pharmacy in San Francisco.
- The Supreme Court joins the multispecialty group practice of the Congress and the President.
- The levonorgestrel intrauterine system in nulliparous women.
- Beyond access: acceptability, use and nonuse of emergency contraception among young women.
- Misoprostol administered by epithelial routes: Drug absorption and uterine response.
- The society of family planning.
- Risk factors associated with presenting for abortion in the second trimester.
- Deaths associated with medication abortion.
- The effect of increased access to emergency contraception among young adolescents.
- HIV sentinel surveillance among women seeking elective pregnancy termination, San Francisco.
- Misoprostol compared with laminaria before early second-trimester surgical abortion: a randomized trial.
- Improving the accuracy of fetal foot length to confirm gestational duration.
- Angiogenic effects of norplant contraception on endometrial histology and uterine bleeding.
- Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial.
- Abortion in the United States.
- Tolerability of levonorgestrel emergency contraception in adolescents.
- Contraceptive use and risk of unintended pregnancy in California.
- Recent developments in hormone delivery systems.
- Adolescent clinic visits for contraception: support from mothers, male partners and friends.
- Manual versus electric vacuum aspiration for early first-trimester abortion: a controlled study of complication rates.
- Prostaglandins for first-trimester termination.
- Advance supply of emergency contraception. effect on use and usual contraception--a randomized trial.
- The effect of training on the provision of elective abortion: a survey of five residency programs.
- Adolescents' contraceptive use and pregnancy history: is there a pattern?
- More on science and politics.
- Abortion: teaching why as well as how.
- Post-abortion depot medroxyprogesterone acetate continuation rates: a randomized trial of cyclic estradiol.
- Recent developments in hormonal contraception.
- Race, adolescent contraceptive choice, and pregnancy at presentation to a family planning clinic.
- Cost-savings from the provision of specific contraceptive methods in 2009.
Schools
University of California At San Francisco
USPHS Hospital
Brigham and Women39s Hospital
Doctors Specialties
- Preventive Medicine
- Obstetrics
- Gynecology
Accepted Insurances
- Medicare Advantage PFFS
- Medicare MCR
Awards
- Elected Member
- Fellow (FACOG)
- Whos Who in Medicine and Healthcare
Education
-
Brigham and Women's Hospital -
University of California San Francisco School of Medicine
Hospital
-
UCSF Medical Center -
San Francisco General Hospital and Trauma Center
Helpful Reviews
Similar Doctors
|
|
Dr. Patricia A. Robertson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles L. Hostetter, MD |
|
|
Dr. Elizabeth A. Galaif, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine B. Powell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Regina L. Arvon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeanette S. Brown, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eleni A. Greenwood, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen K. Smith-McCune, MD
This Doctor is OpenDoctor Recommended.
|